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CORRESPONDENCE
Letters to the Editor
Spontaneous Late
Closure of Patent Foramen Ovale
The study by Meissner et al. (1) and the accompanying editorial by
Meier (2) provide contrasting views concerning the pathologic
significance of patent foramen ovale (PFO). A large autopsy study
from the Mayo Clinic (3) showed a decreasing incidence of PFO
with age that the investigators attributed to late spontaneous
closure, although they did not suggest the mechanism whereby this
might occur. Meier (2) proposes an alternative explanation, namely
that the presence of a PFO is associated with a reduced life
expectancy. Meissner et al. (1) and Siostrzonek et al. (4) note that
a PFO is less frequently detected in patients with elevated left atrial
pressure, but they imply that this is the result of a lower sensitivity
of the detection technique rather than a lower incidence of PFO.
We believe it unlikely that a PFO confers a significant mortality
disadvantage. If this were the case then one would expect a lower
proportion of larger PFOs with age as large PFOs are considered
to confer a higher risk of adverse events (2). Hagen et al. (3) found
the reverse. We believe a more plausible explanation is that a
chronically elevated left atrial pressure as occurs with advancing
age and loss of left ventricular compliance (5) can result in late
closure of a PFO, particularly if small. Indirect evidence for this
assumption comes from an observation that in a personal series
(R.W.H.) of 260 consecutive patients with mitral stenosis under-
going percutaneous trans-septal valvuloplasty, a PFO was crossed
only twice. In this procedure the foramen ovale is always probed
with a catheter stiffened with the trans-septal needle. Accordingly,
if a PFO had been present in these patients with the same
incidence as in the general population (25%), one would have
expected a much higher crossing rate than was observed (1%). In
an otherwise normal heart it is generally very easy to cross a PFO
with a catheter directed at the limbus of the fossa ovalis.
We believe that the likely explanation for the low crossing rate
in mitral stenosis is that the chronically elevated left atrial pressure
associated with this condition results in closure of a PFO. We also
believe that the lower detection rate of PFO in conditions with
elevated left atrial pressure may be the result of late closure of the
PFO rather than an inability to detect the condition.
*Richard W. Harper, MBBS, FRACP, FACC
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Patent Foramen Ovale and
the Risk of Cryptogenic Stroke
We would like to congratulate Meissner et al. on their impressive
cohort study of patent foramen ovale (PFO) and stroke. However,
we hold significant reservations on the stated conclusion that PFO
is not an independent risk factor for future cerebrovascular events
in the general population (1).
The population studied by Meissner et al. (1) was predomi-
nately elderly, with a mean age of nearly 70 years ( 13 years). The
association of PFO and stroke is much less conclusive in older
populations, with conflicting studies (2,3). Increasing age is asso-
ciated with increasing incidence of traditional risk factors for
atheroembolic stroke—clearly demonstrated in this study where
over 50% of subjects were hypertensive and over 50% had visible
aortic plaque (1). It is likely that mechanisms other than paradox-
ical embolism predominate in these older age groups. The plausi-
bility of a congenital defect suddenly causing a cerebrovascular
ischemic event is intuitively much less.
Additionally, it appears no attempt was made to identify those
ischemic strokes that were considered “cryptogenic.” These repre-
sent the minority of the total strokes (4), but they have been most
often associated with PFO (5).
The management of PFO and cryptogenic stroke is an evolving
area (6). There are currently at least 3 recruiting trials of PFO
closure versus medical management. Of note, all specify an upper
age limit for enrollment of 60 years (7–9). The results of these
trials are eagerly awaited.
*Ryan G. Schrale, MBBS, FRACP
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